NO893367L - Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren. - Google Patents
Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren.Info
- Publication number
- NO893367L NO893367L NO89893367A NO893367A NO893367L NO 893367 L NO893367 L NO 893367L NO 89893367 A NO89893367 A NO 89893367A NO 893367 A NO893367 A NO 893367A NO 893367 L NO893367 L NO 893367L
- Authority
- NO
- Norway
- Prior art keywords
- mac
- molecules
- leukocyte adhesion
- adhesion receptor
- subunit
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23535388A | 1988-08-23 | 1988-08-23 | |
US32123989A | 1989-03-09 | 1989-03-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO893367D0 NO893367D0 (no) | 1989-08-22 |
NO893367L true NO893367L (no) | 1990-02-26 |
Family
ID=26928829
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO89893367A NO893367L (no) | 1988-08-23 | 1989-08-22 | Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren. |
Country Status (13)
Country | Link |
---|---|
US (3) | US5849896A (fr) |
EP (1) | EP0364690A3 (fr) |
JP (1) | JPH0347077A (fr) |
KR (1) | KR0185964B1 (fr) |
AU (1) | AU638937B2 (fr) |
CA (1) | CA1341293C (fr) |
DK (1) | DK412489A (fr) |
FI (1) | FI893917A (fr) |
HU (1) | HU213014B (fr) |
IL (1) | IL91370A (fr) |
NO (1) | NO893367L (fr) |
NZ (1) | NZ230397A (fr) |
PT (1) | PT91502B (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0303692A4 (en) * | 1987-02-26 | 1990-12-05 | Dana Farber Cancer Institute | Cloning of lfa-1 |
US5395929A (en) * | 1987-12-15 | 1995-03-07 | Dana Farber Cancer Institute | Isolated nucleic acid encoding the alpha subunit of the human leukocyte adhesion receptor |
US5877275A (en) * | 1988-06-28 | 1999-03-02 | The General Hospital Corporation | Controlling cellular immune/inflammatory responses with β2 integrins |
EP0364690A3 (fr) | 1988-08-23 | 1990-07-18 | Dana Farber Cancer Institute | Sous-unité du récepteur d'adhésion de leukocyte Mac-1 |
US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
ZA896668B (en) * | 1988-09-01 | 1990-06-27 | Molecular Therapeutics Inc | A human rhinovirus receptor protein that inhibits virus infectivity |
ZA901842B (en) * | 1989-03-09 | 1990-12-28 | Boehringer Ingelheim Pharma | Use of intercellular adhesion molecules,and their binding ligans in the treatment of asthma |
EP0462184A4 (en) * | 1989-03-09 | 1992-01-08 | Dana Farber Cancer Institute | Method of treating viral infections using lfa-1 |
US5686582A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric forms of human rhinovirus receptor protein |
US5686581A (en) * | 1990-07-20 | 1997-11-11 | Bayer Corporation | Multimeric form of human rhinovirus receptor protein |
US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
EP0468257B1 (fr) * | 1990-07-20 | 1999-09-01 | Bayer Corporation | Formes multimériques du récepteur du rhinovirus humain |
AU674556B2 (en) * | 1992-10-09 | 1997-01-02 | Center For Blood Research, Inc., The | A subpopulation of MAC-1 molecules which mediate neutrophil adhesion to ICAM-1 and fibrinogen |
JPH09512426A (ja) * | 1994-04-26 | 1997-12-16 | ファルマシア・アンド・アップジョン・カンパニー | 好中球の接着および移動の遮断に有用なMac−1 I−ドメイン蛋白質 |
CA2193508A1 (fr) * | 1994-07-11 | 1996-01-25 | Eugene D. Thorsett | Inhibiteurs de l'adhesion leucocytaire |
US5696229A (en) * | 1995-03-16 | 1997-12-09 | The University Of Virginia Patent Foundation | Polypeptide with laminin cell adhesion and morphogenesis activity |
US6037454A (en) * | 1996-11-27 | 2000-03-14 | Genentech, Inc. | Humanized anti-CD11a antibodies |
US7400477B2 (en) | 1998-08-24 | 2008-07-15 | Leviton Manufacturing Co., Inc. | Method of distribution of a circuit interrupting device with reset lockout and reverse wiring protection |
US6210897B1 (en) | 1999-05-26 | 2001-04-03 | Leif Andersson | Identification of canine leukocyte adhesion deficiency in dogs |
EP1267926A2 (fr) | 2000-03-17 | 2003-01-02 | Millennium Pharmaceuticals, Inc. | Methode d'inhibition de la stenose et de la restenose |
WO2002018583A2 (fr) | 2000-09-01 | 2002-03-07 | The Center For Blood Research, Inc. | Polypeptides modifiés stabilisés dans une conformation souhaitée et procédés de production correspondants |
US7372678B2 (en) * | 2005-08-24 | 2008-05-13 | Leviton Manufacturing Co., Inc. | Circuit interrupting device with automatic test |
US7852606B2 (en) * | 2005-08-24 | 2010-12-14 | Leviton Manufacturing Company, Inc. | Self-testing circuit interrupting device |
US7911746B2 (en) * | 2006-06-01 | 2011-03-22 | Leviton Manufacturing Co., Inc. | GFCI with self-test and remote annunciation capabilities |
US8603628B2 (en) * | 2007-04-30 | 2013-12-10 | Saint-Gobain Performance Plastics Corporation | Turbine blade protective barrier |
WO2009097469A1 (fr) * | 2008-01-29 | 2009-08-06 | Leviton Manufacturing Co., Inc. | Appareil et procédé d'interrupteur de circuit détecteur de défaut à autocontrôle |
US9759758B2 (en) | 2014-04-25 | 2017-09-12 | Leviton Manufacturing Co., Inc. | Ground fault detector |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4761371A (en) * | 1985-02-12 | 1988-08-02 | Genentech, Inc. | Insulin receptor |
US5424399A (en) * | 1988-06-28 | 1995-06-13 | The Children's Medical Center Corporation | Human CR3α/β heterodimers |
EP0364690A3 (fr) | 1988-08-23 | 1990-07-18 | Dana Farber Cancer Institute | Sous-unité du récepteur d'adhésion de leukocyte Mac-1 |
-
1989
- 1989-08-17 EP EP89115159A patent/EP0364690A3/fr not_active Ceased
- 1989-08-21 CA CA000608918A patent/CA1341293C/fr not_active Expired - Lifetime
- 1989-08-21 FI FI893917A patent/FI893917A/fi not_active Application Discontinuation
- 1989-08-21 IL IL9137089A patent/IL91370A/en not_active IP Right Cessation
- 1989-08-22 DK DK412489A patent/DK412489A/da not_active Application Discontinuation
- 1989-08-22 JP JP1215869A patent/JPH0347077A/ja active Pending
- 1989-08-22 NZ NZ230397A patent/NZ230397A/en unknown
- 1989-08-22 HU HU894264A patent/HU213014B/hu unknown
- 1989-08-22 NO NO89893367A patent/NO893367L/no unknown
- 1989-08-22 PT PT91502A patent/PT91502B/pt not_active IP Right Cessation
- 1989-08-22 AU AU40144/89A patent/AU638937B2/en not_active Expired
- 1989-08-23 KR KR1019890011971A patent/KR0185964B1/ko not_active IP Right Cessation
-
1995
- 1995-05-03 US US08/433,801 patent/US5849896A/en not_active Expired - Lifetime
-
1997
- 1997-11-26 US US08/979,940 patent/US20020022595A1/en not_active Abandoned
-
2002
- 2002-05-20 US US10/147,873 patent/US6683158B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU4014489A (en) | 1990-03-01 |
FI893917A (fi) | 1990-02-24 |
EP0364690A3 (fr) | 1990-07-18 |
FI893917A0 (fi) | 1989-08-21 |
US20020022595A1 (en) | 2002-02-21 |
US5849896A (en) | 1998-12-15 |
CA1341293C (fr) | 2001-09-18 |
PT91502A (pt) | 1990-03-08 |
HU213014B (en) | 1997-01-28 |
KR0185964B1 (ko) | 1999-05-01 |
IL91370A (en) | 1995-07-31 |
PT91502B (pt) | 1995-05-04 |
IL91370A0 (en) | 1990-04-29 |
HUT54207A (en) | 1991-01-28 |
DK412489D0 (da) | 1989-08-22 |
US6683158B2 (en) | 2004-01-27 |
EP0364690A2 (fr) | 1990-04-25 |
KR900002797A (ko) | 1990-03-23 |
DK412489A (da) | 1990-02-24 |
NZ230397A (en) | 1997-07-27 |
US20030013850A1 (en) | 2003-01-16 |
AU638937B2 (en) | 1993-07-15 |
JPH0347077A (ja) | 1991-02-28 |
NO893367D0 (no) | 1989-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO893367L (no) | Alfa-underenheten av mac-1 leukocytadhesjons-reseptoren. | |
NO893366L (no) | Alfa-underenheten til lfa-1 leukocytadhesjons-reseptoren. | |
ES2102367T3 (es) | Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion. | |
DE69333109D1 (de) | Therapeutische nukleoside | |
ES2124373T3 (es) | Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico. | |
TR200003461T2 (tr) | Adenosin A3 Alıcı Modülatörleri | |
ES2058083T3 (es) | Anticuerpos monoclonales contra el factor humano de la necrosis tumoral (tnf) y su empleo. | |
ATE61357T1 (de) | Substituierte phenylsulfonamide. | |
AU1130392A (en) | Synthetic htlv-iii peptides, compositions and uses thereof | |
ES2117123T3 (es) | Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina. | |
CO4290432A1 (es) | Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos. | |
ES2080800T3 (es) | Polipeptidos y analogos de polipeptidos con actividad inhibitoria frente a la elastasa humana. | |
ATE306549T1 (de) | C-c ckr-1, ein c-c chemokin rezeptor | |
ES2109658T3 (es) | Determinacion de motivos peptidicos en moleculas del mhc. | |
DK472887A (da) | Imidazolylguanidinderivater, fremgangsmaade til fremstilling deraf og laegemidler, der indeholder disse forbindelser | |
IT1207498B (it) | Procedimento per la preparazione di composizioni plasto-elastomeriche poliolefiniche, mediante vulcanizzazione dinamica. | |
NO892125D0 (no) | Kombinasjon av angiotensin-omvandlende-enzymhemmere med kaliumkanal-modulatorer samt deres anvendelse i legemidler. | |
NO995693D0 (no) | Guanidinylering av reagenser | |
GB1320759A (en) | Apparatus for sewage treatment | |
DK163566C (da) | Anvendelse af hygromycin og epihygromycin til fremstilling af et medikament til behandling af svinedysenteri | |
FR2456095A2 (fr) | Preparation de benzoxazolone | |
ATE25247T1 (de) | 4-amino-3-imidazolin-2-on und (2-methoxy-2-imino- ethyl)-harnstoff, ihre herstellung und verwendung. | |
DE69532611D1 (de) | Mittel zur behandlung von autoimmunkrankheiten | |
SE9603726D0 (sv) | Novel compounds | |
ES2169750T3 (es) | Utilizacion de ribonucleasa seminal como compuesto antimetastatica. |